Reimbursement
Update:
the reimbursement of Velcade® (bortezomib) should be requested through eHealth as of 1/5/2018. In addition, the Velcade list price 3,5 mg and 1 mg has been decreased.
For more information, please download the official communication.
Supporting materials
- Velcade practical guide
- Velcade SC administration form
- Click on following links for more information on:
Risk minimisation plan (RMP)
- Updated Velcade RMA materials (RMA: risk minimisation activities) are now available. The RMP includes the necessary measures to guarantee safe and effective use of Velcade and includes following documents for health care professionals (HCP):
- Summary of Product Characteristics
- Reconstitution, dosing and administration booklet
- Reconstitution poster
- Dosing slide rule
- Inducation transplant regimen graphs
CP-218816 - March 2021
© Janssen-Cilag NV. Deze site wordt onderhouden door Janssen-Cilag NV die als enige verantwoordelijk is voor de inhoud. Deze website is bedoeld voor Healthcare Professionals uit België en G.H. Luxemburg.
